Free Trial
→ This Signal Only Flashes Once Every 4 Years – And It Just Triggered (From Crypto Swap Profits) (Ad) Buy LMAT Stock  Free LMAT Stock Alerts

LeMaitre Vascular (LMAT) Financials

LeMaitre Vascular logo
$81.01 -1.67 (-2.02%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$81.02 +0.01 (+0.01%)
As of 05/28/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for LeMaitre Vascular

Annual Income Statements for LeMaitre Vascular

This table shows LeMaitre Vascular's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders		 44 30 21 27 21 18 23 17 11 7.76 3.92
Consolidated Net Income / (Loss)		 44 30 21 27 21 18 23 17 11 7.76 3.92
Net Income / (Loss) Continuing Operations		 44 30 21 27 21 18 23 17 11 7.76 3.92
Total Pre-Tax Income 		57 39 27 34 27 22 28 21 16 11 6.32
Total Operating Income		 52 37 27 36 29 21 28 21 16 12 6.34
Total Gross Profit		 151 127 105 101 85 80 74 71 63 54 48
Total Revenue		 220 193 162 154 129 117 106 101 89 78 71
Operating Revenue		 220 193 162 154 129 117 106 101 89 78 71
Total Cost of Revenue		 69 66 57 53 45 37 32 30 26 24 23
Operating Cost of Revenue		 69 66 57 53 45 37 32 30 26 24 23
Total Operating Expenses		 99 90 78 65 56 59 46 50 47 43 42
Selling, General & Admin Expense		 36 32 29 26 23 19 18 17 14 14 14
Marketing Expense		 47 41 33 28 24 30 27 26 26 23 22
Research & Development Expense		 16 17 13 12 10 9.28 8.20 6.64 6.14 5.48 4.67
Total Other Income / (Expense), net		 4.62 2.76 0.66 -2.14 -1.43 0.50 0.24 0.00 -0.09 -0.09 -0.02
Interest Expense		 0.21 0.00 0.00 2.22 1.31 0.00 0.00 0.02 0.01 - 0.01
Interest & Investment Income		 4.95 3.08 0.99 0.20 0.21 0.70 0.63 0.18 0.08 0.01 0.00
Other Income / (Expense), net		 -0.13 -0.31 -0.33 -0.12 -0.33 -0.20 -0.39 -0.16 -0.16 -0.10 -0.02
Income Tax Expense		 13 9.37 6.85 7.38 6.14 3.75 5.50 3.93 5.65 3.67 2.41
Basic Earnings per Share		 $1.96 $1.36 $0.94 $1.27 $1.05 $0.91 $1.18 $0.91 $0.57 $0.44 $0.24
Weighted Average Basic Shares Outstanding		 22.45M 22.22M 21.98M 21.16M 20.25M 19.81M 19.43M 18.96M 18.49M 17.76M 16.61M
Diluted Earnings per Share		 $1.93 $1.34 $0.93 $1.25 $1.04 $0.88 $1.13 $0.86 $0.55 $0.42 $0.23
Weighted Average Diluted Shares Outstanding		 22.78M 22.42M 22.17M 21.48M 20.48M 20.33M 20.24M 20.03M 19.24M 18.32M 17.01M
Weighted Average Basic & Diluted Shares Outstanding		 22.56M 22.34M 22.10M 21.93M 20.53M 20.18M 18.67M 18.90M 18.60M 17.60M 16.30M
Cash Dividends to Common per Share		 $0.64 $0.56 $0.50 $0.44 $0.38 $0.34 $0.28 $0.22 $0.18 $0.16 $0.14

Quarterly Income Statements for LeMaitre Vascular

This table shows LeMaitre Vascular's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 11 11 11 12 9.89 8.47 7.50 8.10 6.04 5.63 5.46
Consolidated Net Income / (Loss)		 11 11 11 12 9.89 8.47 7.50 8.10 6.04 5.63 5.46
Net Income / (Loss) Continuing Operations		 11 11 11 12 9.89 8.47 7.50 8.10 6.04 5.63 5.46
Total Pre-Tax Income 		14 14 15 16 13 11 9.83 10 8.02 7.80 6.15
Total Operating Income		 13 13 13 14 12 10 9.18 9.45 7.87 6.97 6.15
Total Gross Profit		 41 39 37 38 37 33 31 32 31 26 25
Total Revenue		 60 56 55 56 53 49 47 50 47 41 39
Operating Revenue		 60 56 55 56 53 49 47 50 47 41 39
Total Cost of Revenue		 18 17 18 17 17 16 17 18 16 15 14
Operating Cost of Revenue		 18 17 18 17 17 16 17 18 16 15 14
Total Operating Expenses		 29 26 24 24 25 23 22 23 23 19 19
Selling, General & Admin Expense		 10 9.49 8.93 8.82 9.01 8.44 7.74 7.72 7.93 6.93 7.23
Marketing Expense		 14 13 11 11 12 10 9.67 10 11 8.60 8.23
Research & Development Expense		 4.10 3.62 3.66 4.28 4.09 4.35 4.22 4.52 3.88 3.55 3.46
Total Other Income / (Expense), net		 1.62 1.17 1.40 1.13 0.92 1.11 0.65 0.87 0.14 0.83 -0.00
Interest Expense		 1.29 - - - - - - - - - -
Interest & Investment Income		 2.90 1.61 1.20 1.14 1.00 0.99 0.84 0.68 0.57 0.45 0.26
Other Income / (Expense), net		 0.00 -0.24 0.20 -0.01 -0.08 0.12 -0.19 0.19 -0.43 0.38 -0.27
Income Tax Expense		 3.23 2.84 3.41 3.68 2.91 2.85 2.32 2.22 1.98 2.17 0.69
Basic Earnings per Share		 $0.49 $0.49 $0.50 $0.53 $0.44 $0.39 $0.34 $0.36 $0.27 $0.25 $0.25
Weighted Average Basic Shares Outstanding		 22.57M 22.45M 22.48M 22.46M 22.37M 22.22M 22.26M 22.21M 22.11M 21.98M 21.98M
Diluted Earnings per Share		 $0.48 $0.48 $0.49 $0.52 $0.44 $0.38 $0.33 $0.36 $0.27 $0.25 $0.25
Weighted Average Diluted Shares Outstanding		 22.90M 22.78M 22.84M 22.73M 22.57M 22.42M 22.48M 22.45M 22.27M 22.17M 22.22M
Weighted Average Basic & Diluted Shares Outstanding		 22.59M 22.56M 22.48M 22.47M 22.45M 22.34M 22.26M 22.26M 22.16M 22.10M 22.00M
Cash Dividends to Common per Share		 $0.20 $0.16 $0.16 $0.16 $0.16 $0.14 $0.14 $0.14 $0.14 $0.13 $0.13

Annual Cash Flow Statements for LeMaitre Vascular

This table details how cash moves in and out of LeMaitre Vascular's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents		 -0.39 5.14 5.28 65 15 -15 7.22 -5.19 -3.16 8.76 3.98
Net Cash From Operating Activities		 44 37 25 35 35 14 20 23 17 11 5.51
Net Cash From Continuing Operating Activities		 44 37 25 35 35 14 20 23 17 11 5.51
Net Income / (Loss) Continuing Operations		 44 30 21 27 21 18 23 17 11 7.76 3.92
Consolidated Net Income / (Loss)		 44 30 21 27 21 18 23 17 11 7.76 3.92
Depreciation Expense		 9.67 9.52 9.43 11 8.40 5.42 4.32 4.06 3.59 3.39 3.33
Non-Cash Adjustments To Reconcile Net Income		 11 7.68 9.02 7.68 4.47 3.72 -3.93 2.85 2.21 1.36 2.23
Changes in Operating Assets and Liabilities, net		 -20 -11 -14 -11 0.72 -13 -3.83 -1.22 0.51 -1.07 -3.97
Net Cash From Investing Activities		 -200 -25 -10 -61 -53 -24 -7.06 -29 -17 -3.48 -7.75
Net Cash From Continuing Investing Activities		 -200 -25 -10 -61 -53 -24 -7.06 -29 -17 -3.48 -7.75
Purchase of Property, Plant & Equipment		 -6.96 -7.27 -3.23 -4.88 -2.98 -3.76 -3.05 -6.42 -2.84 -2.27 -1.17
Acquisitions		 0.00 -0.90 0.00 0.00 -73 -21 -12 0.00 -14 -1.58 -6.57
Purchase of Investments		 -278 -17 -8.00 -59 -2.21 -23 -20 -23 0.00 - -
Sale of Property, Plant & Equipment		 0.00 0.00 0.86 0.00 2.02 0.00 0.00 - - 0.02 -
Sale and/or Maturity of Investments		 85 0.00 0.00 3.00 23 24 21 0.00 0.00 - -
Net Cash From Financing Activities		 158 -7.13 -9.23 14 32 -4.62 -4.42 0.08 -2.58 1.08 6.66
Net Cash From Continuing Financing Activities		 156 -7.13 -9.23 92 32 -4.62 -4.42 0.08 -2.58 1.08 6.66
Repayment of Debt		 -3.23 0.00 0.00 39 -28 0.00 0.00 - - - -1.13
Repurchase of Common Equity		 -1.72 -0.85 -0.64 -0.80 -0.57 -0.68 -0.74 -0.78 -0.31 -0.27 -0.21
Payment of Dividends		 -14 -12 -11 -9.34 -7.70 -6.74 -5.45 -4.18 -3.32 -2.85 -2.31
Issuance of Debt		 169 0.00 0.00 - 65 0.00 0.00 - - - -
Issuance of Common Equity		 6.44 6.17 3.47 63 5.97 4.86 2.97 5.50 1.44 4.84 11
Other Financing Activities, net		 0.00 0.00 -1.07 -0.40 -2.80 -2.06 -1.20 -0.46 -0.39 -0.65 -0.52
Effect of Exchange Rate Changes		 -0.77 - - - 0.91 - - 0.82 -0.27 -0.28 -0.45

Quarterly Cash Flow Statements for LeMaitre Vascular

This table details how cash moves in and out of LeMaitre Vascular's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 -0.27 2.88 -1.27 -4.33 2.33 6.22 -1.44 2.81 -2.46 2.22 -3.88
Net Cash From Operating Activities		 9.04 15 14 9.63 5.07 11 12 12 2.28 4.08 7.34
Net Cash From Continuing Operating Activities		 9.04 15 14 9.63 5.07 11 12 12 2.28 4.29 7.34
Net Income / (Loss) Continuing Operations		 11 11 11 12 9.89 8.47 7.50 8.10 6.04 5.63 5.46
Consolidated Net Income / (Loss)		 11 11 11 12 9.89 8.47 7.50 8.10 6.04 5.63 5.46
Depreciation Expense		 2.55 2.48 2.43 2.38 2.38 2.44 2.40 2.33 2.35 2.29 2.33
Non-Cash Adjustments To Reconcile Net Income		 3.97 3.17 2.11 2.91 2.64 1.77 2.01 1.92 1.98 2.04 1.93
Changes in Operating Assets and Liabilities, net		 -8.49 -1.65 -1.43 -7.50 -9.84 -1.93 -0.09 -0.44 -8.09 -5.67 -2.37
Net Cash From Investing Activities		 -4.32 -174 -13 -11 -2.36 -2.26 -9.85 -9.64 -2.96 -0.40 -8.46
Net Cash From Continuing Investing Activities		 -4.32 -174 -13 -11 -2.36 -2.26 -9.85 -9.64 -2.96 -0.40 -8.46
Purchase of Property, Plant & Equipment		 -1.38 -2.04 -1.67 -1.88 -1.37 -1.28 -1.05 -2.80 -2.13 -1.26 -0.46
Acquisitions		 -0.04 - - - 0.00 - -0.47 -0.16 -0.27 - -
Purchase of Investments		 -2.89 -257 -11 -9.13 -0.99 -0.98 -8.33 -6.68 -0.56 - -8.00
Net Cash From Financing Activities		 -5.24 164 -3.15 -2.87 0.04 -2.69 -3.12 0.50 -1.83 -2.12 -2.15
Net Cash From Continuing Financing Activities		 -5.24 162 -3.15 -2.87 0.04 -2.69 -3.12 0.50 -1.83 -2.12 -2.15
Repurchase of Common Equity		 -0.60 -1.35 -0.00 -0.01 -0.36 -0.67 -0.01 -0.01 -0.17 -0.49 -0.00
Payment of Dividends		 -4.52 -3.60 -3.60 -3.59 -3.59 -3.12 -3.12 -3.12 -3.10 -2.75 -2.75
Other Financing Activities, net		 -0.12 -5.17 0.45 0.73 3.99 -5.07 - 3.63 1.45 -0.67 -
Effect of Exchange Rate Changes		 0.25 - - - -0.42 - - - 0.05 - -

Annual Balance Sheets for LeMaitre Vascular

This table presents LeMaitre Vascular's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets		 552 347 310 293 253 188 153 126 102 91 81
Total Current Assets		 402 195 162 140 94 92 94 80 59 58 49
Cash & Equivalents		 26 24 19 14 27 12 26 19 24 27 19
Short-Term Investments		 274 81 64 56 0.21 21 22 23 - - -
Accounts Receivable		 30 25 22 20 20 17 16 15 13 12 11
Inventories, net		 65 58 50 46 45 40 27 21 20 15 17
Prepaid Expenses		 7.48 6.38 6.73 4.19 2.62 3.31 2.92 2.61 1.97 3.56 2.38
Plant, Property, & Equipment, net		 25 22 18 17 15 15 14 12 8.01 7.02 6.88
Total Noncurrent Assets		 125 130 131 136 144 81 45 34 35 25 26
Goodwill		 66 66 66 66 66 40 30 24 23 18 17
Intangible Assets		 36 42 47 53 59 25 14 8.23 9.90 6.34 7.16
Noncurrent Deferred & Refundable Income Taxes		 1.43 1.00 1.75 1.57 1.69 1.08 1.22 1.38 1.40 1.21 1.42
Other Noncurrent Operating Assets		 22 22 17 16 17 15 0.19 0.18 0.16 0.17 0.17
Total Liabilities & Shareholders' Equity		 552 347 310 293 253 188 153 126 102 91 81
Total Liabilities		 215 49 42 39 80 40 23 17 14 13 13
Total Current Liabilities		 31 30 25 22 25 21 20 13 10 10 10
Accounts Payable		 1.76 3.73 2.90 2.34 2.39 2.60 1.73 1.54 1.22 1.37 1.13
Accrued Expenses		 25 24 20 16 18 14 16 9.77 8.80 8.84 7.48
Other Current Liabilities		 4.11 2.50 2.46 3.14 2.73 4.23 2.18 1.88 0.46 0.17 1.44
Total Noncurrent Liabilities		 184 19 17 17 55 19 3.10 3.36 3.94 2.45 3.24
Long-Term Debt		 168 0.00 - - 36 0.00 - - - - -
Noncurrent Deferred & Payable Income Tax Liabilities		 0.09 0.11 0.07 0.07 0.13 1.18 0.48 2.18 1.94 1.68 2.92
Other Noncurrent Operating Liabilities		 16 19 17 17 19 18 2.61 1.19 2.00 0.77 0.33
Commitments & Contingencies		 0.00 0.00 - - - - - - - - 0.00
Total Equity & Noncontrolling Interests		 337 298 268 254 173 148 130 110 88 78 68
Total Preferred & Common Equity		 337 298 268 254 173 148 130 110 88 78 68
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 337 298 268 254 173 148 130 110 88 78 68
Common Stock		 214 201 190 182 115 106 99 93 86 82 76
Retained Earnings		 145 115 98 88 71 57 46 28 15 8.16 3.25
Treasury Stock		 -16 -14 -13 -12 -12 -11 -10 -9.61 -8.83 -8.52 -8.25
Accumulated Other Comprehensive Income / (Loss)		 -6.18 -4.63 -6.03 -3.44 -1.53 -4.01 -3.90 -2.29 -4.58 -4.05 -2.37

Quarterly Balance Sheets for LeMaitre Vascular

This table presents LeMaitre Vascular's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 556 377 363 354 334 326 315 302
Total Current Assets		 408 227 213 203 182 174 165 153
Cash & Equivalents		 25 21 22 27 18 19 17 17
Short-Term Investments		 277 103 91 82 79 71 64 63
Accounts Receivable		 35 32 31 30 24 26 25 20
Inventories, net		 66 65 64 61 56 54 54 48
Prepaid Expenses		 4.55 5.94 5.22 3.86 5.10 4.08 4.62 4.84
Plant, Property, & Equipment, net		 25 24 23 22 21 21 19 15
Total Noncurrent Assets		 123 126 127 129 130 131 131 134
Goodwill		 66 66 66 66 66 66 66 66
Intangible Assets		 34 37 39 40 43 44 46 48
Noncurrent Deferred & Refundable Income Taxes		 1.04 1.31 1.03 0.83 2.33 2.08 1.80 2.79
Other Noncurrent Operating Assets		 21 21 21 22 19 19 18 17
Total Liabilities & Shareholders' Equity		 556 377 363 354 334 326 315 302
Total Liabilities		 208 46 44 45 45 43 41 41
Total Current Liabilities		 25 29 25 27 29 26 24 23
Accounts Payable		 2.18 1.65 2.00 3.09 4.37 3.52 3.37 2.85
Accrued Expenses		 20 23 21 21 22 19 18 17
Other Current Liabilities		 2.64 4.20 2.67 2.60 2.87 3.01 2.91 3.19
Total Noncurrent Liabilities		 184 17 18 19 16 17 17 17
Long-Term Debt		 168 - - - - - - -
Noncurrent Deferred & Payable Income Tax Liabilities		 0.09 0.11 0.10 0.11 0.07 0.07 0.07 0.06
Other Noncurrent Operating Liabilities		 16 16 18 19 16 17 17 17
Total Equity & Noncontrolling Interests		 348 331 320 309 289 284 274 261
Total Preferred & Common Equity		 348 331 320 309 289 284 274 261
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 348 331 320 309 289 284 274 261
Common Stock		 217 211 209 207 198 197 192 187
Retained Earnings		 152 138 130 122 110 106 101 95
Treasury Stock		 -16 -14 -14 -14 -13 -13 -13 -13
Accumulated Other Comprehensive Income / (Loss)		 -5.15 -3.16 -5.09 -5.56 -6.71 -5.82 -5.57 -8.13

Annual Metrics And Ratios for LeMaitre Vascular

This table displays calculated financial ratios and metrics derived from LeMaitre Vascular's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 13.63% 19.69% 4.68% 19.37% 10.35% 11.05% 4.66% 13.14% 13.78% 10.20% 10.14%
EBITDA Growth		 34.60% 27.76% -24.15% 28.56% 39.61% -17.87% 28.54% 26.50% 33.51% 53.29% 35.47%
EBIT Growth		 43.22% 37.33% -27.00% 27.58% 35.64% -24.57% 32.78% 29.51% 41.75% 80.44% 45.85%
NOPAT Growth		 44.52% 39.02% -29.54% 28.01% 27.43% -22.98% 32.48% 61.24% 36.23% 99.07% 17.50%
Net Income Growth		 46.28% 45.89% -23.31% 26.80% 18.32% -21.83% 33.57% 62.20% 36.50% 98.16% 22.27%
EPS Growth		 44.03% 44.09% -25.60% 20.19% 18.18% -22.12% 31.40% 56.36% 30.95% 82.61% 15.00%
Operating Cash Flow Growth		 20.06% 44.81% -27.70% 0.87% 145.43% -27.31% -14.70% 35.35% 47.72% 107.51% 2.30%
Free Cash Flow Firm Growth		 35.13% 9.88% -32.82% 161.13% -192.18% -282.10% -29.83% 676.98% -130.83% 284.67% -80.65%
Invested Capital Growth		 6.49% 3.94% 0.72% 0.31% 59.04% 40.38% 20.76% 7.75% 25.34% 1.85% 18.31%
Revenue Q/Q Growth		 3.21% 4.27% 0.91% 1.28% 6.05% 1.54% 2.16% 2.92% 3.25% 2.35% 1.09%
EBITDA Q/Q Growth		 3.92% 7.30% -4.10% -1.78% 17.64% -6.33% 2.98% 11.63% 3.83% 2.93% 21.27%
EBIT Q/Q Growth		 4.61% 8.88% -3.42% -3.22% 18.45% -8.74% 2.97% 13.24% 4.48% 3.97% 33.90%
NOPAT Q/Q Growth		 6.92% 10.31% -6.84% -3.49% 16.04% -8.28% 8.04% 10.41% 1.40% 7.68% 41.61%
Net Income Q/Q Growth		 6.58% 10.41% -2.59% -3.09% 12.87% -7.30% 8.21% 10.89% 0.64% 8.59% 42.62%
EPS Q/Q Growth		 5.46% 10.74% -2.11% -5.30% 11.83% -7.37% 7.62% 11.69% 0.00% 5.00% 43.75%
Operating Cash Flow Q/Q Growth		 11.18% 22.17% -3.71% -20.58% 32.61% -6.45% -1.01% 12.69% 1.62% 12.19% 31.68%
Free Cash Flow Firm Q/Q Growth		 25.46% 35.44% -14.75% -16.94% 33.98% -1,214.60% -13.32% 1,323.68% -123.58% 26.17% 11.57%
Invested Capital Q/Q Growth		 -0.89% 0.63% 2.20% 1.22% -1.32% 18.52% 3.17% -0.71% 21.47% -0.25% 1.54%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 68.63% 65.66% 64.89% 65.65% 65.41% 68.12% 70.04% 70.09% 70.59% 69.13% 68.12%
EBITDA Margin		 28.11% 23.73% 22.23% 30.68% 28.49% 22.52% 30.44% 24.79% 22.17% 18.90% 13.58%
Operating Margin		 23.77% 18.97% 16.60% 23.59% 22.25% 18.07% 26.72% 20.92% 18.32% 14.69% 8.92%
EBIT Margin		 23.71% 18.81% 16.40% 23.51% 22.00% 17.90% 26.35% 20.77% 18.14% 14.56% 8.89%
Profit (Net Income) Margin		 20.03% 15.56% 12.77% 17.42% 16.40% 15.30% 21.73% 17.03% 11.88% 9.90% 5.51%
Tax Burden Percent		 77.43% 76.26% 75.07% 78.48% 77.57% 82.73% 80.66% 81.38% 65.20% 67.91% 61.95%
Interest Burden Percent		 109.10% 108.45% 103.72% 94.43% 96.12% 103.33% 102.26% 100.75% 100.41% 100.11% 99.94%
Effective Tax Rate		 22.57% 23.74% 24.93% 21.52% 22.43% 17.27% 19.34% 18.62% 34.80% 32.09% 38.05%
Return on Invested Capital (ROIC)		 20.32% 14.80% 10.90% 15.54% 14.93% 17.73% 30.27% 26.16% 18.74% 15.65% 8.60%
ROIC Less NNEP Spread (ROIC-NNEP)		 17.31% 12.56% 10.25% 21.24% 25.21% 16.71% 29.84% 26.15% 18.98% 15.91% 8.67%
Return on Net Nonoperating Assets (RNNOA)		 -6.46% -4.16% -2.99% -2.93% -1.70% -4.84% -11.15% -8.74% -5.94% -5.02% -2.32%
Return on Equity (ROE)		 13.87% 10.64% 7.90% 12.61% 13.23% 12.88% 19.12% 17.41% 12.81% 10.62% 6.28%
Cash Return on Invested Capital (CROIC)		 14.04% 10.93% 10.18% 15.24% -30.65% -15.87% 11.46% 18.70% -3.74% 13.81% -8.18%
Operating Return on Assets (OROA)		 11.60% 11.08% 8.79% 13.31% 12.90% 12.29% 19.91% 18.36% 16.79% 13.25% 8.32%
Return on Assets (ROA)		 9.80% 9.16% 6.84% 9.86% 9.62% 10.51% 16.42% 15.05% 11.00% 9.01% 5.15%
Return on Common Equity (ROCE)		 13.87% 10.64% 7.90% 12.61% 13.23% 12.88% 19.12% 17.41% 12.81% 10.62% 6.28%
Return on Equity Simple (ROE_SIMPLE)		 13.06% 10.11% 7.69% 10.59% 12.30% 12.11% 17.62% 15.65% 12.10% 9.96% 5.74%
Net Operating Profit after Tax (NOPAT)		 40 28 20 29 22 18 23 17 11 7.82 3.93
NOPAT Margin		 18.40% 14.47% 12.46% 18.51% 17.26% 14.95% 21.55% 17.03% 11.95% 9.98% 5.52%
Net Nonoperating Expense Percent (NNEP)		 3.02% 2.24% 0.65% -5.70% -10.27% 1.02% 0.42% 0.01% -0.24% -0.26% -0.07%
Return On Investment Capital (ROIC_SIMPLE)		 8.01% 9.40% 7.51% - - - - - - - -
Cost of Revenue to Revenue		 31.37% 34.34% 35.11% 34.35% 34.59% 31.88% 29.96% 29.91% 29.41% 30.87% 31.88%
SG&A Expenses to Revenue		 16.49% 16.45% 17.78% 16.51% 17.39% 16.25% 16.76% 16.86% 16.10% 17.88% 19.54%
R&D to Revenue		 7.12% 8.77% 8.22% 7.64% 7.81% 7.91% 7.76% 6.58% 6.89% 6.99% 6.57%
Operating Expenses to Revenue		 44.87% 46.69% 48.29% 42.06% 43.16% 50.05% 43.32% 49.17% 52.27% 54.44% 59.20%
Earnings before Interest and Taxes (EBIT)		 52 36 27 36 28 21 28 21 16 11 6.32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 62 46 36 47 37 26 32 25 20 15 9.66
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 6.14 4.21 3.71 4.20 4.61 0.46 3.35 5.22 4.99 3.68 1.76
Price to Tangible Book Value (P/TBV)		 8.80 6.59 6.38 7.88 16.66 0.82 5.03 7.38 8.06 5.33 2.75
Price to Revenue (P/Rev)		 9.42 6.48 6.15 6.91 6.14 0.58 4.13 5.68 4.90 3.66 1.69
Price to Earnings (P/E)		 47.04 41.64 48.18 39.67 37.46 3.80 19.01 33.36 41.24 36.97 30.70
Dividend Yield		 0.69% 0.99% 1.11% 0.90% 0.97% 0.99% 1.26% 0.74% 0.77% 1.01% 2.02%
Earnings Yield		 2.13% 2.40% 2.08% 2.52% 2.67% 26.30% 5.26% 3.00% 2.42% 2.71% 3.26%
Enterprise Value to Invested Capital (EV/IC)		 9.45 5.96 4.91 5.42 4.39 0.31 4.72 7.80 6.53 5.14 2.05
Enterprise Value to Revenue (EV/Rev)		 8.82 5.94 5.64 6.46 6.23 0.30 3.68 5.27 4.63 3.31 1.43
Enterprise Value to EBITDA (EV/EBITDA)		 31.39 25.02 25.37 21.05 21.87 1.35 12.08 21.25 20.87 17.52 10.51
Enterprise Value to EBIT (EV/EBIT)		 37.21 31.56 34.39 27.47 28.32 1.69 13.95 25.37 25.50 22.73 16.05
Enterprise Value to NOPAT (EV/NOPAT)		 47.94 41.02 45.26 34.90 36.09 2.03 17.06 30.94 38.72 33.17 25.84
Enterprise Value to Operating Cash Flow (EV/OCF)		 43.96 31.25 35.92 28.42 23.16 2.50 19.90 23.24 24.41 22.67 18.41
Enterprise Value to Free Cash Flow (EV/FCFF)		 69.41 55.53 48.43 35.60 0.00 0.00 45.06 43.29 0.00 37.58 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.50 0.00 0.00 0.00 0.22 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.50 0.00 0.00 0.00 0.21 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.37 -0.33 -0.29 -0.14 -0.07 -0.29 -0.37 -0.33 -0.31 -0.32 -0.27
Leverage Ratio		 1.41 1.16 1.15 1.28 1.38 1.23 1.16 1.16 1.16 1.18 1.22
Compound Leverage Factor		 1.54 1.26 1.20 1.21 1.32 1.27 1.19 1.17 1.17 1.18 1.22
Debt to Total Capital		 33.22% 0.00% 0.00% 0.00% 18.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 1.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 33.22% 0.00% 0.00% 0.00% 16.87% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 66.78% 100.00% 100.00% 100.00% 81.94% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 2.71 0.00 0.00 0.00 1.03 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -2.14 0.00 0.00 0.00 0.30 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 2.71 0.00 0.00 0.00 0.96 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 4.15 0.00 0.00 0.00 1.70 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -3.26 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 4.15 0.00 0.00 0.00 1.59 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 7.68 17.33 15.88 18.41 7.55 2.89 13.74 23.07 20.35 15.46 7.18
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 13.14 6.51 6.39 6.41 3.75 4.42 4.76 6.09 5.63 5.61 4.84
Quick Ratio		 10.77 4.36 4.13 4.11 1.85 2.36 3.22 4.30 3.58 3.80 2.94
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 28 21 19 28 -46 -16 8.61 12 -2.13 6.90 -3.74
Operating Cash Flow to CapEx		 633.78% 505.86% 1,070.35% 719.01% 3,628.78% 377.00% 638.70% 356.37% 594.72% 506.55% 469.51%
Free Cash Flow to Firm to Interest Expense		 136.33 0.00 0.00 12.63 -34.99 0.00 4,307.22 584.60 -151.98 0.00 -747.32
Operating Cash Flow to Interest Expense		 215.24 0.00 0.00 15.82 26.56 0.00 9,753.00 1,088.95 1,206.86 0.00 1,102.40
Operating Cash Flow Less CapEx to Interest Expense		 181.28 0.00 0.00 13.62 25.83 0.00 8,226.00 783.38 1,003.93 0.00 867.60
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.49 0.59 0.54 0.57 0.59 0.69 0.76 0.88 0.93 0.91 0.94
Accounts Receivable Turnover		 7.98 8.22 7.76 7.88 7.16 7.26 6.87 7.16 7.09 6.88 6.65
Inventory Turnover		 1.12 1.23 1.18 1.16 1.06 1.12 1.31 1.49 1.51 1.52 1.51
Fixed Asset Turnover		 9.45 9.76 9.25 9.62 8.66 8.10 7.97 9.89 11.86 11.27 11.21
Accounts Payable Turnover		 25.10 20.02 21.65 22.41 17.91 17.24 19.32 21.86 20.30 19.40 19.19
Days Sales Outstanding (DSO)		 45.76 44.43 47.05 46.31 50.96 50.27 53.11 51.01 51.51 53.05 54.91
Days Inventory Outstanding (DIO)		 325.52 297.65 309.90 313.85 345.20 326.71 279.47 245.74 242.15 240.85 241.30
Days Payable Outstanding (DPO)		 14.54 18.23 16.86 16.29 20.38 21.17 18.90 16.70 17.98 18.81 19.02
Cash Conversion Cycle (CCC)		 356.74 323.84 340.09 343.87 375.78 355.81 313.68 280.05 275.67 275.09 277.20
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 205 193 186 184 184 115 82 68 63 50 50
Invested Capital Turnover		 1.10 1.02 0.87 0.84 0.87 1.19 1.40 1.54 1.57 1.57 1.56
Increase / (Decrease) in Invested Capital		 13 7.32 1.32 0.57 68 33 14 4.90 13 0.92 7.66
Enterprise Value (EV)		 1,940 1,149 912 998 806 36 388 531 412 259 101
Market Capitalization		 2,072 1,254 994 1,067 795 68 436 573 437 287 120
Book Value per Share		 $15.00 $13.38 $12.19 $11.64 $8.48 $74.39 $6.65 $5.70 $4.71 $4.30 $3.93
Tangible Book Value per Share		 $10.48 $8.55 $7.08 $6.20 $2.35 $41.83 $4.43 $4.03 $2.92 $2.97 $2.52
Total Capital		 505 298 268 254 211 148 130 110 88 78 68
Total Debt		 168 0.00 0.00 0.00 38 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 168 0.00 0.00 0.00 36 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -132 -105 -83 -70 11 -33 -48 -42 -24 -27 -19
Capital Expenditures (CapEx)		 6.96 7.27 2.37 4.88 0.96 3.76 3.05 6.42 2.84 2.26 1.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 72 60 54 48 45 39 26 25 24 20 20
Debt-free Net Working Capital (DFNWC)		 372 165 136 118 72 71 74 67 49 48 39
Net Working Capital (NWC)		 372 165 136 118 69 71 74 67 49 48 39
Net Nonoperating Expense (NNE)		 -3.58 -2.11 -0.50 1.68 1.11 -0.41 -0.19 -0.00 0.06 0.06 0.01
Net Nonoperating Obligations (NNO)		 -132 -105 -83 -70 11 -33 -48 -42 -24 -27 -19
Total Depreciation and Amortization (D&A)		 9.67 9.52 9.43 11 8.40 5.42 4.32 4.06 3.59 3.39 3.33
Debt-free, Cash-free Net Working Capital to Revenue		 32.69% 30.83% 33.23% 31.16% 34.51% 32.89% 24.89% 25.24% 27.21% 25.99% 27.93%
Debt-free Net Working Capital to Revenue		 169.01% 85.13% 84.38% 76.46% 55.36% 60.77% 70.34% 66.55% 54.45% 61.03% 54.22%
Net Working Capital to Revenue		 169.01% 85.13% 84.38% 76.46% 53.43% 60.77% 70.34% 66.55% 54.45% 61.03% 54.22%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.96 $1.36 $0.94 $1.27 $1.05 $0.91 $1.18 $0.91 $0.57 $0.44 $0.24
Adjusted Weighted Average Basic Shares Outstanding		 22.45M 22.22M 21.98M 21.16M 20.25M 19.81M 19.43M 18.96M 18.49M 17.76M 16.61M
Adjusted Diluted Earnings per Share		 $1.93 $1.34 $0.93 $1.25 $1.04 $0.88 $1.13 $0.86 $0.55 $0.42 $0.23
Adjusted Weighted Average Diluted Shares Outstanding		 22.78M 22.42M 22.17M 21.48M 20.48M 20.33M 20.24M 20.03M 19.24M 18.32M 17.01M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 22.56M 22.34M 22.10M 21.93M 20.53M 20.18M 18.67M 19.28M 18.67M 18.34M 17.51M
Normalized Net Operating Profit after Tax (NOPAT)		 40 28 22 29 22 18 17 17 11 7.57 4.40
Normalized NOPAT Margin		 18.40% 14.66% 13.90% 18.51% 16.98% 14.95% 15.84% 17.03% 11.95% 9.67% 6.18%
Pre Tax Income Margin		 25.87% 20.40% 17.01% 22.20% 21.15% 18.49% 26.94% 20.92% 18.22% 14.58% 8.89%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 254.30 0.00 0.00 16.36 21.72 0.00 13,907.50 997.52 1,155.36 0.00 1,264.80
NOPAT to Interest Expense		 197.37 0.00 0.00 12.88 17.05 0.00 11,376.72 817.84 760.81 0.00 785.48
EBIT Less CapEx to Interest Expense		 220.34 0.00 0.00 14.16 20.99 0.00 12,380.50 691.95 952.43 0.00 1,030.00
NOPAT Less CapEx to Interest Expense		 163.41 0.00 0.00 10.68 16.31 0.00 9,849.72 512.26 557.88 0.00 550.68
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 32.65% 41.35% 53.25% 34.70% 36.26% 37.56% 23.73% 24.33% 31.38% 36.67% 58.95%
Augmented Payout Ratio		 36.55% 44.18% 56.36% 37.68% 38.95% 41.37% 26.96% 28.86% 34.32% 40.10% 64.34%

Quarterly Metrics And Ratios for LeMaitre Vascular

This table displays calculated financial ratios and metrics derived from LeMaitre Vascular's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 11.95% 13.98% 15.63% 11.44% 13.60% 19.36% 21.48% 19.02% 18.99% 3.67% 1.72%
EBITDA Growth		 7.07% 18.25% 38.56% 40.04% 44.67% 32.42% 38.65% 52.88% -4.49% -13.74% -31.14%
EBIT Growth		 7.05% 22.24% 48.48% 49.10% 58.36% 40.40% 52.80% 79.09% -5.57% -11.33% -34.63%
NOPAT Growth		 6.41% 34.26% 43.63% 47.85% 54.64% 51.90% 28.42% 102.42% -0.91% -22.47% -22.00%
Net Income Growth		 11.37% 32.12% 48.51% 46.04% 63.69% 50.44% 37.50% 130.38% 0.03% -8.87% -16.11%
EPS Growth		 9.09% 26.32% 48.48% 44.44% 62.96% 52.00% 32.00% 125.00% 0.00% -7.41% -16.67%
Operating Cash Flow Growth		 78.25% 41.28% 20.49% -19.14% 122.51% 163.58% 61.03% 28.71% -51.62% -19.36% -47.84%
Free Cash Flow Firm Growth		 -242.99% -805.02% -77.27% 53.23% 756.54% -91.35% -152.41% -149.52% -107.87% -37.32% -46.74%
Invested Capital Growth		 6.39% 6.49% 8.12% 6.60% 3.65% 3.94% 5.57% 6.20% 3.35% 0.72% -0.25%
Revenue Q/Q Growth		 7.46% 1.64% -1.84% 4.43% 9.40% 3.10% -5.40% 6.46% 14.95% 4.93% -7.31%
EBITDA Q/Q Growth		 0.57% -4.32% -5.83% 18.16% 11.08% 12.10% -4.82% 22.07% 1.67% 17.38% 4.95%
EBIT Q/Q Growth		 0.10% -5.50% -7.09% 21.81% 14.29% 14.79% -6.70% 29.37% 1.33% 24.93% 9.35%
NOPAT Q/Q Growth		 -4.79% 1.85% -8.21% 19.55% 20.13% 8.96% -5.51% 25.04% 18.00% -7.89% 48.94%
Net Income Q/Q Growth		 -1.55% 0.39% -5.79% 19.61% 16.80% 12.84% -7.36% 34.07% 7.34% 3.13% 55.22%
EPS Q/Q Growth		 0.00% -2.04% -5.77% 18.18% 15.79% 15.15% -8.33% 33.33% 8.00% 0.00% 56.25%
Operating Cash Flow Q/Q Growth		 -40.46% 6.57% 48.01% 89.80% -52.81% -9.11% -0.67% 422.29% -44.10% -44.47% -20.61%
Free Cash Flow Firm Q/Q Growth		 -34.01% 58.89% -202.86% -185.69% 560.74% 110.34% 20.10% -1,102.96% -108.70% -37.33% -24.50%
Invested Capital Q/Q Growth		 3.73% -0.89% 0.36% 3.11% 3.83% 0.63% -1.05% 0.25% 4.12% 2.20% -0.46%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 69.18% 69.26% 67.82% 68.88% 68.56% 68.05% 65.00% 64.02% 65.60% 63.62% 64.24%
EBITDA Margin		 25.35% 27.09% 28.78% 30.00% 26.51% 26.11% 24.02% 23.87% 20.82% 23.54% 21.04%
Operating Margin		 21.09% 23.07% 23.98% 25.75% 22.20% 20.88% 19.36% 18.86% 16.73% 17.01% 15.76%
EBIT Margin		 21.09% 22.64% 24.35% 25.73% 22.06% 21.11% 18.96% 19.23% 15.82% 17.95% 15.08%
Profit (Net Income) Margin		 18.39% 20.07% 20.32% 21.18% 18.49% 17.32% 15.82% 16.16% 12.83% 13.74% 13.98%
Tax Burden Percent		 77.32% 79.77% 76.57% 76.27% 77.26% 74.83% 76.35% 78.48% 75.34% 72.16% 88.74%
Interest Burden Percent		 112.77% 111.14% 109.00% 107.91% 108.49% 109.61% 109.29% 107.08% 107.63% 106.08% 104.49%
Effective Tax Rate		 22.68% 20.23% 23.43% 23.73% 22.74% 25.17% 23.65% 21.52% 24.66% 27.84% 11.26%
Return on Invested Capital (ROIC)		 17.86% 20.32% 19.62% 20.19% 17.43% 15.98% 14.70% 13.95% 11.22% 10.73% 12.33%
ROIC Less NNEP Spread (ROIC-NNEP)		 16.83% 19.54% 18.65% 19.34% 16.68% 15.10% 14.15% 13.13% 11.08% 9.95% 12.33%
Return on Net Nonoperating Assets (RNNOA)		 -6.23% -7.29% -6.65% -6.52% -5.42% -5.01% -4.55% -4.02% -3.16% -2.91% -3.55%
Return on Equity (ROE)		 11.63% 13.03% 12.97% 13.67% 12.01% 10.97% 10.16% 9.93% 8.06% 7.83% 8.78%
Cash Return on Invested Capital (CROIC)		 13.68% 14.04% 11.17% 11.00% 12.29% 10.93% 8.19% 6.64% 7.28% 10.18% 12.15%
Operating Return on Assets (OROA)		 10.49% 11.08% 14.59% 15.34% 13.18% 12.43% 11.06% 10.89% 8.82% 9.62% 8.17%
Return on Assets (ROA)		 9.15% 9.82% 12.18% 12.63% 11.05% 10.20% 9.23% 9.15% 7.15% 7.36% 7.57%
Return on Common Equity (ROCE)		 11.63% 13.03% 12.97% 13.67% 12.01% 10.97% 10.16% 9.93% 8.06% 7.83% 8.78%
Return on Equity Simple (ROE_SIMPLE)		 12.99% 0.00% 12.48% 11.79% 11.01% 0.00% 9.45% 8.89% 7.53% 0.00% 8.11%
Net Operating Profit after Tax (NOPAT)		 9.76 10 10 11 9.17 7.64 7.01 7.42 5.93 5.03 5.46
NOPAT Margin		 16.31% 18.40% 18.36% 19.64% 17.15% 15.62% 14.78% 14.80% 12.60% 12.28% 13.98%
Net Nonoperating Expense Percent (NNEP)		 1.03% 0.79% 0.97% 0.84% 0.75% 0.88% 0.56% 0.82% 0.14% 0.79% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 1.89% 2.03% - - - 2.56% - - - 1.87% -
Cost of Revenue to Revenue		 30.82% 30.74% 32.18% 31.12% 31.44% 31.95% 35.00% 35.98% 34.40% 36.38% 35.76%
SG&A Expenses to Revenue		 17.52% 17.04% 16.30% 15.79% 16.85% 17.27% 16.32% 15.41% 16.85% 16.93% 18.52%
R&D to Revenue		 6.84% 6.49% 6.67% 7.67% 7.65% 8.90% 8.91% 9.01% 8.23% 8.68% 8.87%
Operating Expenses to Revenue		 48.09% 46.19% 43.84% 43.13% 46.36% 47.17% 45.63% 45.16% 48.88% 46.61% 48.48%
Earnings before Interest and Taxes (EBIT)		 13 13 13 14 12 10 8.99 9.64 7.45 7.35 5.88
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 15 15 16 17 14 13 11 12 9.80 9.64 8.21
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.45 6.14 6.30 5.77 4.79 4.21 4.16 5.19 4.09 3.71 4.18
Price to Tangible Book Value (P/TBV)		 7.66 8.80 9.16 8.58 7.30 6.59 6.70 8.47 6.89 6.38 7.42
Price to Revenue (P/Rev)		 8.37 9.42 9.80 8.96 7.39 6.48 6.48 8.32 6.63 6.15 6.82
Price to Earnings (P/E)		 41.91 47.04 50.51 48.92 43.48 41.64 44.08 58.42 54.36 48.18 51.54
Dividend Yield		 0.81% 0.69% 0.67% 0.73% 0.88% 0.99% 1.24% 0.80% 1.01% 1.11% 0.98%
Earnings Yield		 2.39% 2.13% 1.98% 2.04% 2.30% 2.40% 2.27% 1.71% 1.84% 2.08% 1.94%
Enterprise Value to Invested Capital (EV/IC)		 8.25 9.45 9.48 8.38 6.83 5.96 5.77 7.14 5.39 4.91 5.58
Enterprise Value to Revenue (EV/Rev)		 7.77 8.82 9.22 8.41 6.84 5.94 5.95 7.81 6.15 5.64 6.32
Enterprise Value to EBITDA (EV/EBITDA)		 27.99 31.39 33.01 31.41 27.20 25.02 25.82 34.92 29.34 25.37 27.01
Enterprise Value to EBIT (EV/EBIT)		 33.20 37.21 39.39 38.04 33.58 31.56 33.05 45.62 39.93 34.39 36.88
Enterprise Value to NOPAT (EV/NOPAT)		 42.83 47.94 51.88 49.74 43.80 41.02 43.53 58.16 51.82 45.26 46.81
Enterprise Value to Operating Cash Flow (EV/OCF)		 36.56 43.96 49.47 46.43 34.60 31.25 36.73 54.04 45.36 35.92 38.40
Enterprise Value to Free Cash Flow (EV/FCFF)		 62.22 69.41 88.14 78.65 56.58 55.53 72.35 110.81 75.25 48.43 45.84
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.48 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.48 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.37 -0.37 -0.36 -0.34 -0.32 -0.33 -0.32 -0.31 -0.29 -0.29 -0.29
Leverage Ratio		 1.39 1.41 1.15 1.14 1.15 1.16 1.16 1.16 1.14 1.15 1.16
Compound Leverage Factor		 1.56 1.57 1.25 1.23 1.25 1.27 1.26 1.24 1.23 1.23 1.21
Debt to Total Capital		 32.58% 33.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 32.58% 33.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 67.42% 66.78% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 2.67 2.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -2.14 -2.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 2.67 2.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 4.09 4.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -3.28 -3.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 4.09 4.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 7.14 7.44 29.07 27.21 21.24 17.08 17.55 22.37 18.14 15.68 17.61
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 16.49 13.14 7.74 8.36 7.57 6.51 6.28 6.75 6.89 6.39 6.53
Quick Ratio		 13.65 10.77 5.32 5.66 5.17 4.36 4.16 4.51 4.45 4.13 4.26
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -3.03 -2.26 -5.50 -1.82 2.12 0.32 -3.10 -3.88 -0.32 3.71 5.92
Operating Cash Flow to CapEx		 653.58% 742.76% 853.05% 512.51% 370.15% 840.19% 1,122.79% 424.65% 107.00% 323.57% 1,596.09%
Free Cash Flow to Firm to Interest Expense		 -2.35 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 7.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 5.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.50 0.49 0.60 0.60 0.60 0.59 0.58 0.57 0.56 0.54 0.54
Accounts Receivable Turnover		 6.92 7.98 7.59 7.19 7.19 8.22 8.44 7.39 7.24 7.76 8.09
Inventory Turnover		 1.12 1.12 1.11 1.13 1.17 1.23 1.27 1.25 1.18 1.18 1.20
Fixed Asset Turnover		 9.57 9.45 9.41 9.28 9.65 9.76 10.11 9.58 9.42 9.25 9.90
Accounts Payable Turnover		 26.79 25.10 22.40 24.09 20.76 20.02 18.21 19.83 21.33 21.65 18.51
Days Sales Outstanding (DSO)		 52.71 45.76 48.10 50.79 50.76 44.43 43.25 49.39 50.44 47.05 45.11
Days Inventory Outstanding (DIO)		 326.95 325.52 327.94 322.92 311.23 297.65 288.53 292.28 308.87 309.90 303.18
Days Payable Outstanding (DPO)		 13.62 14.54 16.29 15.15 17.58 18.23 20.05 18.41 17.11 16.86 19.72
Cash Conversion Cycle (CCC)		 366.04 356.74 359.75 358.56 344.41 323.84 311.74 323.26 342.19 340.09 328.57
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 213 205 207 206 200 193 192 194 193 186 182
Invested Capital Turnover		 1.10 1.10 1.07 1.03 1.02 1.02 0.99 0.94 0.89 0.87 0.88
Increase / (Decrease) in Invested Capital		 13 13 16 13 7.06 7.32 10 11 6.26 1.32 -0.46
Enterprise Value (EV)		 1,758 1,940 1,963 1,730 1,368 1,149 1,105 1,383 1,041 912 1,012
Market Capitalization		 1,893 2,072 2,087 1,843 1,476 1,254 1,202 1,474 1,122 994 1,092
Book Value per Share		 $15.41 $15.00 $14.73 $14.24 $13.81 $13.38 $12.96 $12.81 $12.41 $12.19 $11.89
Tangible Book Value per Share		 $10.96 $10.48 $10.14 $9.57 $9.06 $8.55 $8.06 $7.85 $7.36 $7.08 $6.70
Total Capital		 516 505 331 320 309 298 289 284 274 268 261
Total Debt		 168 168 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 168 168 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -135 -132 -124 -113 -108 -105 -97 -90 -81 -83 -80
Capital Expenditures (CapEx)		 1.38 2.04 1.67 1.88 1.37 1.28 1.05 2.80 2.13 1.26 0.46
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 81 72 74 74 68 60 56 58 60 54 50
Debt-free Net Working Capital (DFNWC)		 383 372 198 187 176 165 153 149 141 136 130
Net Working Capital (NWC)		 383 372 198 187 176 165 153 149 141 136 130
Net Nonoperating Expense (NNE)		 -1.25 -0.93 -1.07 -0.86 -0.71 -0.83 -0.49 -0.68 -0.11 -0.60 0.00
Net Nonoperating Obligations (NNO)		 -135 -132 -124 -113 -108 -105 -97 -90 -81 -83 -80
Total Depreciation and Amortization (D&A)		 2.55 2.48 2.43 2.38 2.38 2.44 2.40 2.33 2.35 2.29 2.33
Debt-free, Cash-free Net Working Capital to Revenue		 35.72% 32.69% 34.68% 36.12% 33.95% 30.83% 30.25% 33.00% 35.39% 33.23% 31.19%
Debt-free Net Working Capital to Revenue		 169.44% 169.01% 92.84% 91.12% 88.13% 85.13% 82.54% 83.89% 83.27% 84.38% 80.96%
Net Working Capital to Revenue		 169.44% 169.01% 92.84% 91.12% 88.13% 85.13% 82.54% 83.89% 83.27% 84.38% 80.96%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.49 $0.49 $0.50 $0.53 $0.44 $0.39 $0.34 $0.36 $0.27 $0.25 $0.25
Adjusted Weighted Average Basic Shares Outstanding		 22.57M 22.45M 22.48M 22.46M 22.37M 22.22M 22.26M 22.21M 22.11M 21.98M 21.98M
Adjusted Diluted Earnings per Share		 $0.48 $0.48 $0.49 $0.52 $0.44 $0.38 $0.33 $0.36 $0.27 $0.25 $0.25
Adjusted Weighted Average Diluted Shares Outstanding		 22.90M 22.78M 22.84M 22.73M 22.57M 22.42M 22.48M 22.45M 22.27M 22.17M 22.22M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 22.59M 22.56M 22.48M 22.47M 22.45M 22.34M 22.26M 22.26M 22.16M 22.10M 22.00M
Normalized Net Operating Profit after Tax (NOPAT)		 9.76 10 10 11 9.17 7.64 7.01 7.56 6.16 5.03 5.46
Normalized NOPAT Margin		 16.31% 18.40% 18.36% 19.64% 17.15% 15.62% 14.78% 15.08% 13.09% 12.28% 13.98%
Pre Tax Income Margin		 23.79% 25.16% 26.54% 27.76% 23.93% 23.14% 20.73% 20.59% 17.03% 19.04% 15.75%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 9.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 7.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 8.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 6.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 33.89% 32.65% 33.63% 35.60% 38.11% 41.35% 44.31% 46.45% 54.97% 53.25% 50.25%
Augmented Payout Ratio		 38.24% 36.55% 36.13% 38.35% 41.17% 44.18% 46.79% 49.12% 58.21% 56.36% 52.98%

Frequently Asked Questions About LeMaitre Vascular's Financials

When does LeMaitre Vascular's fiscal year end?

According to the most recent income statement we have on file, LeMaitre Vascular's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has LeMaitre Vascular's net income changed over the last 10 years?

LeMaitre Vascular's net income appears to be on an upward trend, with a most recent value of $44.04 million in 2024, rising from $3.92 million in 2014. The previous period was $30.11 million in 2023. Find out what analysts predict for LeMaitre Vascular in the coming months.

What is LeMaitre Vascular's operating income?
LeMaitre Vascular's total operating income in 2024 was $52.26 million, based on the following breakdown:
  • Total Gross Profit: $150.90 million
  • Total Operating Expenses: $98.65 million
How has LeMaitre Vascular revenue changed over the last 10 years?

Over the last 10 years, LeMaitre Vascular's total revenue changed from $71.10 million in 2014 to $219.86 million in 2024, a change of 209.2%.

How much debt does LeMaitre Vascular have?

LeMaitre Vascular's total liabilities were at $214.53 million at the end of 2024, a 338.9% increase from 2023, and a 1,514.8% increase since 2014.

How much cash does LeMaitre Vascular have?

In the past 10 years, LeMaitre Vascular's cash and equivalents has ranged from $11.79 million in 2019 to $27.45 million in 2015, and is currently $25.61 million as of their latest financial filing in 2024.

How has LeMaitre Vascular's book value per share changed over the last 10 years?

Over the last 10 years, LeMaitre Vascular's book value per share changed from 3.93 in 2014 to 15.00 in 2024, a change of 282.1%.


Related Companies

This page (NASDAQ:LMAT) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored